MedTrace Logo

PrEPARE: PrEP in Pregnancy, Accelerating Reach and Efficiency

NCT04712994 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1958

Last updated 2025-01-08

Study results available
· View outcomes & findings →

Summary

This study tests strategies for improving PrEP implementation in maternal and child health clinics using a difference-in-difference approach.

Conditions

  • Pre-Exposure Prophylaxis
  • HIV Infections
  • Pregnancy Related

Interventions

OTHER

PrEP Optimization Interventions

A bundle of strategies (video-based PrEP counselling, HIV Self-Testing \[HIVST\] for women undergoing repeat HIV testing, and optimized PrEP delivery and prescription processes) will be implemented in the intervention group.

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • University of Washington

    lead OTHER

Principal Investigators

  • Grace John-Stewart, MD, MPH, PhD · University of Washington

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2021-11-30
Completion
2022-01-31

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04712994 on ClinicalTrials.gov